United States Market

USA Market

21 CFR Part 801 Labeling

MEDICAL-DEVICE

Medical Device

IVD

IVD

ENQUIRE NOW

    What is 21 CFR Part 801 Labeling?

    21 CFR Part 801 is a critical regulation issued by the Food and Drug Administration (FDA) that sets forth specific requirements for the labeling of medical devices sold in the United States. Labeling includes all written, printed, or graphic materials that accompany a medical device, including product labels, packaging, instructions for use, and promotional materials. Compliance with Part 801 is crucial for medical device manufacturers to ensure the proper marketing, use, and safety of their products.

    Why is 21 CFR Part 801 Labeling important?

    Compliance with 21 CFR Part 801 is vital for medical device manufacturers to ensure the safety and effectiveness of medical devices. It facilitates market access in the United States.

    Process Flow for 21 CFR Part 801 Labeling

    process counter bg

    Determine Applicability

    process counter bg

    Labeling Design and Creation

    process counter bg

    Quality Control and Verification

    process counter bg

    Labeling Review and Approval

    process counter bg

    Labeling Printing and Application

    process counter bg

    Storage and Distribution

    process counter bg

    Regulatory Submissions

    process counter bg

    Labeling Updates

    process counter bg

    Post-Market Surveillance

    process counter bg

    Audits and Inspection

    How can we help in 21 CFR Part 801 Labeling?

    The CliniExperts Professionals will:

    technical documentation

    Assist in all sort of documentation.

    We-Can-help

    Comply with FDA regulations to avoid regulatory actions, recalls, and penalties.

    We-can-assist

    Help in maintaining product quality and reputation in the market.

    We-can-help-you-find

    Facilitate market access and commercial success in the United States.

    help illustration Glow Icon

    Regulatory requirements for 21 CFR Part 801 Labeling

    Documents

    Documents

    Compliance with 21 CFR Part 801 requires the creation and maintenance of various labeling documents. These documents typically include labels, packaging materials, user instructions, and any additional information required to be included with the medical device.

    Timeline

    Timeline

    The timeline can range from several months to over a year, depending on the extent of changes needed and the efficiency of the implementation process.

    Regulatory-Body

    Regulatory Body

    The regulatory body responsible for 21 CFR Part 801 labeling requirements in the United States is the U.S. Food and Drug Administration (FDA). The FDA oversees and enforces regulations related to the labeling of medical devices to ensure that they provide clear and accurate information to healthcare professionals and patients.

    Fees

    Fees

    The fees for consulting services can vary depending on the consulting firm, the scope of work, and the complexity of the labeling requirements.

    Validity

    Validity

    Compliance with 21 CFR Part 801 labeling is an ongoing commitment and does not have a specific expiration date. Regular internal audits and assessments are crucial to maintaining labeling validity.

    Send us your query on Regulatory Services in EU, USA and UK market

    HAVE A QUERY?
    REACH US!

    ENQUIRE NOW